Search research articles
Contact Us
Filters
Showing results (11-20 of 230) with videos related to
Page
of 23
Sort By:
Journal of Neural Transmission. Supplementum
|
November 29, 2002
Microangiopathy-related cerebral damage and angiotensinogen gene: from epidemiology to biology
H Schmidt, F Fazekas, R Schmidt
European Neurology
|
January 1, 1983
Hemorheological effects of pentoxifylline on disturbed flow behavior of blood in patients with cerebrovascular insufficiency
E Ott, H Lechner, F Fazekas
Journal of Neurology
|
April 6, 2000
Vascular risk factors in dementia
R Schmidt, H Schmidt, F Fazekas
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 1, 1998
Unenhanced and enhanced magnetic resonance imaging in the diagnosis of multiple sclerosis
F Fazekas, F Barkhof, M Filippi
European Journal of Neurology
|
May 15, 2020
The European Academy of Neurology is 6 years old: challenges, opportunities and strategic priorities for the future
C L A Bassetti, F Fazekas
Journal of Neural Transmission. Supplementum
|
November 29, 2002
Can small-vessel disease-related cerebral abnormalities be used as a surrogate marker for vascular dementia trials?
F Fazekas, S Ropele, R Schmidt
Practical Neurology
|
September 19, 2009
Neurological letter from Austria
W Poewe, E Auff, F Fazekas
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 26, 1998
Cerebral ischemia and Alzheimer's disease: critical role of PET and implications for therapeutic intervention
A Alavi, C Clark, F Fazekas
Dementia and Geriatric Cognitive Disorders
|
August 26, 1998
Pathophysiologic mechanisms in the development of age-related white matter changes of the brain
F Fazekas, R Schmidt, P Scheltens
European Neurology
|
January 1, 1997
What is the role of ancillary investigations in establishing the diagnosis of multiple sclerosis?
F Fazekas, H Offenbacher, H P Hartung
Page
of 23
Search research articles
Search
Showing results (11-20 of 230) with videos related to
Sort By:
Page
of 23
Journal of Neural Transmission. Supplementum
|
November 29, 2002
Microangiopathy-related cerebral damage and angiotensinogen gene: from epidemiology to biology
H Schmidt, F Fazekas, R Schmidt
European Neurology
|
January 1, 1983
Hemorheological effects of pentoxifylline on disturbed flow behavior of blood in patients with cerebrovascular insufficiency
E Ott, H Lechner, F Fazekas
Journal of Neurology
|
April 6, 2000
Vascular risk factors in dementia
R Schmidt, H Schmidt, F Fazekas
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 1, 1998
Unenhanced and enhanced magnetic resonance imaging in the diagnosis of multiple sclerosis
F Fazekas, F Barkhof, M Filippi
European Journal of Neurology
|
May 15, 2020
The European Academy of Neurology is 6 years old: challenges, opportunities and strategic priorities for the future
C L A Bassetti, F Fazekas
Journal of Neural Transmission. Supplementum
|
November 29, 2002
Can small-vessel disease-related cerebral abnormalities be used as a surrogate marker for vascular dementia trials?
F Fazekas, S Ropele, R Schmidt
Practical Neurology
|
September 19, 2009
Neurological letter from Austria
W Poewe, E Auff, F Fazekas
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 26, 1998
Cerebral ischemia and Alzheimer's disease: critical role of PET and implications for therapeutic intervention
A Alavi, C Clark, F Fazekas
Dementia and Geriatric Cognitive Disorders
|
August 26, 1998
Pathophysiologic mechanisms in the development of age-related white matter changes of the brain
F Fazekas, R Schmidt, P Scheltens
European Neurology
|
January 1, 1997
What is the role of ancillary investigations in establishing the diagnosis of multiple sclerosis?
F Fazekas, H Offenbacher, H P Hartung
Page
of 23